Together, the associations between heparin associated comorbidities and AD/ApoE4 carriage indicate that although the set of AD/Heparin(+) and AD/Heparin(−) patients are likely confounded by differential disease burden, the biases might be expected to minimize the observation of any true protective effect of heparin upon AD diagnosis. Here, APOE is linked to Alzheimer disease.